New mask aims to reduce breathing effort in ventilation patients
NCT ID NCT07484802
First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tests a redesigned non-invasive ventilation mask that may help people with respiratory insufficiency breathe more easily. Sixty adults who are stable on NIV will wear their usual mask for one hour and then the new mask for one hour. Researchers will measure breathing rate, air leak, and comfort to see if the new mask performs better.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- non-invasive ventilation mask with airway washout
- What this could lead to
- If it works, this new mask could make breathing easier and more comfortable for people who need non-invasive ventilation.
- What could go wrong
- This is a small, early-stage study with only 60 participants, each using the mask for just one hour. It may not show a meaningful benefit or work for everyone.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
About 60 people
The number the study aims to enrol. It can still change while the study runs.
- Expected to start
-
Jul 2026
An estimate. Start dates often move.
- Expected to finish
-
Dec 2027
An estimate. End dates often move.
- Lead sponsor
-
A company
The lead sponsor is a pharmaceutical, biotech, or medical-device company.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
21 years and older
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Adults that are stable on prescribed NIV * Able to receive NIV therapy on a sub-nasal mask * Are 21 years old or older Exclusion Criteria: * Contraindicated for NIV * NIV is likely to fail and/or intubation be required, at the doctor's discretion * CPAP or bilevel pressure of ≥ 30 cmH2O required * Do not fit the investigation mask or the standard mask * Pregnancy (tested under standard care) * Unable to tolerate NIV for the duration of the investigation * Unable to understand the consent process
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Respiratory failure are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
How to take part
Only the study team decides who joins. These are the ways to reach them.
-
The official record
ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.
-
A doctor treating you
A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can tilting a Patient's body toward the infection help them breathe free sooner?
- Can a machine breathe better than a nurse? automated oxygen system tested in COPD
- Can a battery keep ventilators running during ambulance transport?
- Can a simple ultrasound combo predict breathing failure before it happens?
- Could stepping down breathing support sooner save more lives?
- A global effort to make moving critically ill patients safer